Finance

Lists
IMRX:NASDAQ
Immuneering Corp
$5.36
+6.46%
(+0.32) 1D
Aug 19, 3:43:15 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for IMRX...
Open
$5.18
High
$5.36
Low
$5.14
Mkt. cap
346.45M
Avg. vol.
766.38K
Volume
556.31K
52-wk high
$10.08
52-wk low
$3.25
EPS
-$1.03
Beta
0.43
Shares outstanding
64.70M
No. of employees
57
Open
$5.18
High
$5.36
Low
$5.14
Mkt. cap
346.45M
Avg. vol.
766.38K
Volume
556.31K
52-wk high
$10.08
52-wk low
$3.25
EPS
-$1.03
Beta
0.43
Shares outstanding
64.70M
No. of employees
57
News stories
From web sources and news partners
About Immuneering Corp
CEO-
Employees57
Founded2008
Headquarters-
SectorBiotechnology
Websiteimmuneering.com
Analyst ratings
Based on 5 analysts giving stock ratings to IMRX in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for IMRX in the last 3 months.
Highest
Current $5.36
$18.00 (+236.13%)
Average
$14.60 (+172.64%)
Lowest
$12.00 (+124.09%)
Analyst
Recommendation
Action
Price target
Projected
Date
Allison Bratzel
Piper Sandler
Buy
Maintained
$12.00
+124.1%
08/17/2026
Graig Suvannavejh
Mizuho Securities
Buy
Maintained
$12.00
+124.1%
08/06/2026
Andres Y. Maldonado
H.C. Wainwright
Buy
Initiated
$14.00
+161.4%
08/06/2026
Ami Fadia
Needham
Buy
Reiterated
$18.00
+236.1%
08/05/2026
Li Watsek
Cantor Fitzgerald
Buy
Initiated
$17.00
+217.5%
07/08/2026
Geulah Livshits
Chardan Capital
Buy
Reiterated
$20.00
+273.5%
05/19/2026
Jay Olson
Oppenheimer
Buy
Reiterated
$30.00
+460.2%
03/09/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
10.87M
9.25M
10.65M
14.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.51M
4.49M
4.68M
5.00M
Operating expense
15.38M
13.75M
15.34M
19.00M
Total operating expenses
15.38M
13.75M
15.34M
19.00M
Operating income
-15.38M
-13.75M
-15.34M
-19.00M
Other non operating income
-
155.92K
109.01K
647.20K
EBT including unusual items
-14.96M
-11.58M
-13.46M
-17.27M
EBT excluding unusual items
-14.96M
-11.74M
-13.87M
-17.27M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-14.96M
-11.58M
-13.46M
-17.27M
Net profit margin
-
-
-
-
Earnings per share
-0.38
-0.18
-0.21
-0.27
Interest and investment income
415.83K
1.86M
1.36M
1.08M
Interest expense
-
-
-
-
Net interest expenses
415.83K
1.86M
1.36M
1.08M
Depreciation and amortization charges
-
-
-
-
EBITDA
-15.29M
-13.67M
-15.25M
-18.91M
Gain or loss from assets sale
-
2.09K
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps